Health Problems
In reversal, FDA panel votes to recommend experimental ALS drug
A Food and Drug Administration advisory panel voted Wednesday to recommend an experimental drug for patients with ALS, a reversal from its decision in March and a victory for advocacy groups pushing for the drug’s approval. The 7-2 vote by the agency’s Peripheral and Central Nervous System Drugs Advisory Committee Read more…